(Q44340018)

English

Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils (English)

1 reference

Europe PubMed Central

2 December 2017

author name string

K E S Plath

1

1 reference

Europe PubMed Central

2 December 2017

J Grabbe

2

1 reference

Europe PubMed Central

2 December 2017

B F Gibbs

3

1 reference

Europe PubMed Central

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

2 December 2017

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

2 December 2017

33

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

342-350

1 reference

Europe PubMed Central

2 December 2017

Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Purification of morphologically and functionally intact human basophils to near homogeneity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Fc epsilon RI-mediated induction of nuclear factor of activated T-cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Guidelines for doctors in North America

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Mechanisms and pharmacologic control of basophil-derived IL-4 and IL-13

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Immunohistochemical detection of human basophils in postmortem cases of fatal asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Structure-activity profiles of macrolactam immunosuppressant FK-506 analogues

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Treatment of steroid-dependent bronchial asthma with cyclosporin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01610.X

21 January 2018

Identifiers

10.1046/J.1365-2222.2003.01610.X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44340018&oldid=2109567531"